Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nextleaf SolutionsSTU:L0MA PS Ratio is 0.47 as of Jul. 24, 2026, which is 88% below its 10-year median of 3.89. The stock has 4 warning signs investors should review. Among 952 Drug Manufacturers companies, Nextleaf Solutions ranks better than 81.2% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Nextleaf Solutions's share price is €0.018.
Nextleaf Solutions's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €0.04. Hence, Nextleaf Solutions's PS Ratio for today is 0.47.
The historical rank and industry rank for Nextleaf Solutions's PS Ratio or its related term are showing as below:
STU:L0MA'
s PS Ratio Range Over the Past 10 Years
Min: 0.66 Med: 3.89 Max: 640
Current: 0.82
During the past 9 years, Nextleaf Solutions's highest PS Ratio was 640.00. The lowest was 0.66. And the median was 3.89.
STU:L0MA's PS Ratio is ranked better than 81.2% of 952
companies
in the Drug Manufacturers industry
Industry Median: 2.24
vs STU:L0MA: 0.82
Nextleaf Solutions Ltd revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Nextleaf Solutions was -17.60% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 28.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 57.10% per year.
During the past 9 years, Nextleaf Solutions's highest 3-Year average Revenue per Share Growth Rate was 108.00% per year. The lowest was 28.60% per year. And the median was 74.90% per year.
Back to Basics: PS Ratio
Nextleaf Solutions (STU:L0MA) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Nextleaf Solutions PS Ratio Related Terms
Nextleaf Solutions PS Ratio Historical Data
* Premium members only.
The historical data trend for Nextleaf Solutions's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Nextleaf Solutions's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nextleaf Solutions PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Nextleaf Solutions's PS Ratio distribution charts can be found below:
* The bar in red indicates where Nextleaf Solutions's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Nextleaf Solutions's Share Price of today is €0.018. Nextleaf Solutions's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.04.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Nextleaf Solutions (STU:L0MA) has a PS Ratio of 0.47 as of Jul. 24, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Nextleaf Solutions and its competitors. This is 88% below median its historical median of 3.89. Over the past decade, Nextleaf Solutions' PS Ratio has ranged from 0.66 to 640.00. According to the industry distribution chart, Nextleaf Solutions ranks #179 out of 952 companies in the Drug Manufacturers industry, placing it in the top 18.8%.
Is Nextleaf Solutions' PS Ratio too high?
Nextleaf Solutions' current PS Ratio of 0.47 is 88% below median its 10-year median of 3.89. Over the past 10 years, this metric has ranged from a low of 0.66 to a high of 640.00. The Drug Manufacturers industry median PS Ratio is 2.24. Nextleaf Solutions' value of 0.47 is 79% below this industry median. Based on the distribution chart, Nextleaf Solutions ranks #179 out of 952 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Nextleaf Solutions' PS Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Nextleaf Solutions ranks #179 out of 952 companies for PS Ratio. This places Nextleaf Solutions in the top 19% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.24. Nextleaf Solutions' value of 0.47 is 79% below this benchmark. Historically, Nextleaf Solutions' own PS Ratio has ranged from 0.66 to 640.00 over the past decade. While the company's 10-year median is 3.89 vs. the industry median of 2.24, Nextleaf Solutions has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.24, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nextleaf Solutions's current PS Ratio of 0.47 is 79% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Nextleaf Solutions and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nextleaf Solutions's current PS Ratio is 0.47, which is 88% below median its own 10-year median of 3.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nextleaf Solutions stock overvalued right now?
Nextleaf Solutions (STU:L0MA) has a current PS Ratio of 0.47. The stock's GF Value™ is €0.02, compared to a current price of €0.02 — trading 10% below its estimated fair value. The current PS Ratio is 0.47, which is 88% below median its 10-year median of 3.89 and 79% below the Drug Manufacturers industry median of 2.24. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Nextleaf Solutions (STU:L0MA), the current PS Ratio is 0.47 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Nextleaf Solutions Ltd is is a Canadian cannabis extractor and processor, with a focus on developing intellectual property for the extraction, distillation formulation, and delivery of cannabinoids. The Company has a single reportable segment being the provision of goods and services to the cannabis industry in Canada. All the Company's revenues are generated in Canada. Revenue from sale of goods and services includes sales of bulk distillate, branded (Glacial Gold) vape pens, oils, and softgels (branded extract products), and private label which includes toll processing and other services. Majority being from Branded extract products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:L0MA has been successfully added to your 
